Literature DB >> 4097158

[Correlation of thromboplastin times in dicumarol treated patients using various preparations of thrombokinase].

R Averdunk, K Borner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4097158

Source DB:  PubMed          Journal:  Z Klin Chem Klin Biochem        ISSN: 0044-2933


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.

Authors:  J A Zix; H F Geerdes-Fenge; M Rau; J Vöckler; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  [Standardization of the Quick test. Reference thromboplastin of reference plasma?].

Authors:  R Averdunk; K Borner
Journal:  Blut       Date:  1974-06

3.  [Activity of reagents for thromboplastin-time determination (Quick test) of various manufacturers in changing concentrations of several blood coagulation factors].

Authors:  R Averdunk; J S Braun
Journal:  Blut       Date:  1972-05

4.  [Partial thromboplastin time. Change in time by alteration of the concentration of single blood coagulation factors using reagents from various producers. Effect of heparin on partial thromboplastin time].

Authors:  R Averdunk; J S Braun
Journal:  Blut       Date:  1972-06

5.  Determination of cefmenoxime in human body fluids by high-performance liquid chromatography.

Authors:  K Borner; E Borner; H Lode; A Peters
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

6.  Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography.

Authors:  K Borner; H Lode; A Elvers
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

7.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

8.  Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.

Authors:  W Paulfeuerborn; H J Müller; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.

Authors:  D Kampf; R Schurig; I Korsukewitz; O Brückner
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors:  G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.